These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 8230103

  • 1. The interaction of ammonium, sulfonium, and sulfide analogues of metoclopramide with the dopamine D2 receptor.
    Harrold MW, Sriburi A, Matsumoto K, Miller DD, Farooqui T, Uretsky N.
    J Med Chem; 1993 Oct 15; 36(21):3166-70. PubMed ID: 8230103
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and D2 dopaminergic activity of pyrrolidinium, tetrahydrothiophenium, and tetrahydrothiophene analogues of sulpiride.
    Harrold MW, Wallace RA, Farooqui T, Wallace LJ, Uretsky N, Miller DD.
    J Med Chem; 1989 Apr 15; 32(4):874-80. PubMed ID: 2522993
    [Abstract] [Full Text] [Related]

  • 3. Charged analogues of chlorpromazine as dopamine antagonists.
    Harrold MW, Chang YA, Wallace RA, Farooqui T, Wallace LJ, Uretsky N, Miller DD.
    J Med Chem; 1987 Sep 15; 30(9):1631-5. PubMed ID: 2887659
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interaction of permanently charged metoclopramide analogs with D-2 dopamine receptors.
    Farooqui T, Brooks K, Harrold MW, Miller DD, Wallace LJ, Uretsky NJ.
    Gen Pharmacol; 1994 Dec 15; 25(8):1577-84. PubMed ID: 7721031
    [Abstract] [Full Text] [Related]

  • 6. Interaction of permanently charged chlorpromazine and dopamine analogs with the striatal D-1 dopaminergic receptor.
    Wallace RA, Wallace L, Harrold M, Miller D, Uretsky NJ.
    Biochem Pharmacol; 1989 Jun 15; 38(12):2019-25. PubMed ID: 2525907
    [Abstract] [Full Text] [Related]

  • 7. Cardioselective ammonium, phosphonium, and sulfonium analogues of alpha-tocopherol and ascorbic acid that inhibit in vitro and ex vivo lipid peroxidation and scavenge superoxide radicals.
    Grisar JM, Marciniak G, Bolkenius FN, Verne-Mismer J, Wagner ER.
    J Med Chem; 1995 Jul 21; 38(15):2880-6. PubMed ID: 7636848
    [Abstract] [Full Text] [Related]

  • 8. Effect of permanently charged and uncharged dopaminergic agonists on the potassium-induced release of [3H]acetylcholine from striatal slices.
    Sabol B, Boldry R, Farooqui T, Chang YA, Miller D, Uretsky N.
    Biochem Pharmacol; 1987 May 15; 36(10):1679-85. PubMed ID: 3109428
    [Abstract] [Full Text] [Related]

  • 9. BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
    Gylys JA, Wright RN, Nicolosi WD, Buyniski JP, Crenshaw RR.
    J Pharmacol Exp Ther; 1988 Mar 15; 244(3):830-7. PubMed ID: 2978041
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
    Hirokawa Y, Harada H, Yoshikawa T, Yoshida N, Kato S.
    Chem Pharm Bull (Tokyo); 2002 Jul 15; 50(7):941-59. PubMed ID: 12130853
    [Abstract] [Full Text] [Related]

  • 11. A central site of action for benzamide facilitation of gastric emptying.
    Costall B, Gunning SJ, Naylor RJ, Simpson KH.
    Eur J Pharmacol; 1983 Jul 22; 91(2-3):197-205. PubMed ID: 6617741
    [Abstract] [Full Text] [Related]

  • 12. Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists.
    King FD, Hadley MS, McClelland CM.
    J Med Chem; 1988 Sep 22; 31(9):1708-12. PubMed ID: 2900897
    [Abstract] [Full Text] [Related]

  • 13. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN, Jenner P, Huizing G, Marsden CD, Miller R.
    Neuropharmacology; 1977 May 22; 16(5):333-42. PubMed ID: 559256
    [No Abstract] [Full Text] [Related]

  • 14. Investigation on central dopaminergic receptors (D-2) using the antagonistic properties of new benzamides.
    Rumigny JF, Strolin Benedetti M, Dostert P.
    J Pharm Pharmacol; 1984 Jun 22; 36(6):373-7. PubMed ID: 6146667
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. (E)-(methyloxyimino)acetamides as analogues of neuroleptic benzamides: synthesis and D2-dopaminergic binding affinity.
    Lapucci A, Macchia M, Orlandini E, Romagnoli F, Rossello A, Chiellini G, Cozzini P, Domiano P.
    Farmaco; 1996 Jan 22; 51(1):33-9. PubMed ID: 8721759
    [Abstract] [Full Text] [Related]

  • 17. Trivalent sulfonium compounds (TSCs): Tetrahydrothiophene-based amphiphiles exhibit similar antimicrobial activity to analogous ammonium-based amphiphiles.
    Feliciano JA, Leitgeb AJ, Schrank CL, Allen RA, Minbiole KPC, Wuest WM, Carden RG.
    Bioorg Med Chem Lett; 2021 Apr 01; 37():127809. PubMed ID: 33516911
    [Abstract] [Full Text] [Related]

  • 18. Interaction of AZA analogs of chlorpromazine with the dopamine D2 receptor.
    Farooqui T, Markovich K, Wallace L, Miller D, Uretsky N.
    Gen Pharmacol; 1993 Jan 01; 24(1):147-51. PubMed ID: 8482489
    [Abstract] [Full Text] [Related]

  • 19. Substituted benzamides with conformationally restricted side chains. 1. Quinolizidine derivatives as selective gastric prokinetic agents.
    Hadley MS, King FD, McRitchie B, Turner DH, Watts EA.
    J Med Chem; 1985 Dec 01; 28(12):1843-7. PubMed ID: 4068007
    [Abstract] [Full Text] [Related]

  • 20. Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides.
    Kato S, Morie T, Hino K, Kon T, Naruto S, Yoshida N, Karasawa T, Matsumoto J.
    J Med Chem; 1990 May 01; 33(5):1406-13. PubMed ID: 2139471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.